Merck KGaA Unveils $11.3 Billion Acquisition of Bio-Techne to Reshape Life Sciences Landscape
In a landmark move that promises to redraw the boundaries of the global life sciences sector, Merck KGaA, Darmstadt, Germany,...
acquisition
AbbVie’s $10.9 Billion Acquisition of Apogee Therapeutics: A Strategic Pivot in the Immunology Arms Race
SAN DIEGO — In a move that signals a significant intensification of the global battle for dominance in the immunology...
GSK Bolsters Oncology Portfolio with $10.6 Billion Acquisition of Nuvalent
In a move that signals a significant shift in its long-term growth strategy, GlaxoSmithKline (GSK) has officially announced a definitive...
